Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor
Which treatments are currently available for relapsed and refractory myeloma treatment?
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
What’s next for Richter’s syndrome?
Conversations doctors must have with CLL patients